drugset
drugset / Trial / NCT03642873

Study to Evaluate Drug-drug Interactions of Guaifenesin and Hydrocodone Bitartrate

NCT03642873 ↗

Phase 1 Completed 24 enrolled Reckitt Benckiser Inc.
RandomizedCrossoverOpen-labelSupportive care

Summary

Determine and compare the plasma concentrations and safety and tolerability of Guaifenesin and hydrocodone bitartrate when they are administered alone or in combination to normal healthy male and/or female subjects.

Timeline

Start
2007-05-05
Primary completion
2007-05-21
Completion
2007-05-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Guaifenesin Small molecule 1200 mg Oral
Subject Hydrocodone Unknown 3.33 mg Oral

Indications

No indication recorded.